Lithotripsy Devices Market

Lithotripsy Devices Market Size and Share Forecast Outlook 2025 to 2035

The Lithotripsy Devices Market is estimated to be valued at USD 1.7 billion in 2025 and is projected to reach USD 2.7 billion by 2035, registering a compound annual growth rate (CAGR) of 4.9% over the forecast period.

Quick Stats for Lithotripsy Devices Market

• Lithotripsy Devices Market Value (2025): USD 1.7 billion
• Lithotripsy Devices Market Forecast Value (2035): USD 2.7 billion
• Lithotripsy Devices Market Forecast CAGR: 4.9%
• Leading Segment in Lithotripsy Devices Market in 2025: Extracorporeal Shock Wave Lithotripsy Devices (61.3%)
• Key Growth Regions in Lithotripsy Devices Market: North America, Asia-Pacific, Europe
• Top Key Players in Lithotripsy Devices Market: Richard Wolf GmbH, MedTech, Bio-Rad Laboratories, Inc., Olympus Corporation, Boston Scientific Corporation, Abaxis, Hologic Inc., DirexGroup, KARL STORZ SE & Co. KG, Lumenis Be Ltd., Dornier MedTech, Walz Elektronik GmbH

Lithotripsy Devices Market Key Takeaways

Metric	Value
Lithotripsy Devices Market Estimated Value in (2025 E)	USD 1.7 billion
Lithotripsy Devices Market Forecast Value in (2035 F)	USD 2.7 billion
Forecast CAGR (2025 to 2035)	4.9%

Why is the Lithotripsy Devices Market Growing?

The lithotripsy devices market is experiencing strong growth due to the increasing prevalence of kidney stone disorders and rising demand for minimally invasive treatment options. The adoption of technologically advanced devices that reduce patient discomfort and procedure time is being prioritized across hospitals and specialized medical centers. Growing awareness of non-surgical treatment alternatives, coupled with an aging population and lifestyle-related health conditions, is further driving market expansion.

Advancements in extracorporeal and focused energy delivery systems are enhancing treatment efficacy, safety, and recovery times, which strengthens clinical preference for lithotripsy solutions. Investments in hospital infrastructure and the proliferation of diagnostic imaging facilities are facilitating early detection and timely intervention for urinary disorders. Increasing healthcare expenditure and reimbursement support in several regions are enabling broader adoption of high-performance devices.

As regulatory standards for medical devices continue to ensure safety and efficiency, the market is positioned for sustained growth The focus on integrating real-time imaging guidance and energy optimization technologies is expected to open new avenues for product differentiation and competitive advantage in the coming decade.

Segmental Analysis

The lithotripsy devices market is segmented by type, application, end user, and geographic regions. By type, lithotripsy devices market is divided into Extracorporeal Shock Wave Lithotripsy Devices and Intracorporeal Lithotripsy Devices. In terms of application, lithotripsy devices market is classified into Kidney Stones, Ureteral Stones, Pancreatic Stones, and Bile Duct Stones. Based on end user, lithotripsy devices market is segmented into Hospitals, Ambulatory Surgical Centers, and Speciality Clinics. Regionally, the lithotripsy devices industry is classified into North America, Latin America, Western Europe, Eastern Europe, Balkan & Baltic Countries, Russia & Belarus, Central Asia, East Asia, South Asia & Pacific, and the Middle East & Africa.

Insights into the Extracorporeal Shock Wave Lithotripsy Devices Type Segment

The extracorporeal shock wave lithotripsy devices segment is projected to account for 61.3% of the lithotripsy devices market revenue share in 2025, making it the leading type. Its dominance is being driven by the non-invasive nature of shock wave procedures, which minimize patient risk and reduce recovery time compared with traditional surgical methods. The segment benefits from advancements in precision targeting and energy modulation, which improve fragmentation efficiency for kidney stones of varying sizes and compositions.

Hospitals and specialized clinics are increasingly adopting these devices due to their compatibility with outpatient procedures and their ability to reduce procedural costs. Proven clinical effectiveness, patient safety, and procedural versatility are reinforcing market preference.

Furthermore, the ability to integrate imaging guidance systems and real-time monitoring software enhances treatment accuracy, increasing adoption in high-volume healthcare facilities Ongoing innovation and the scalability of device platforms are expected to sustain the segment’s leadership in the market over the forecast period.

Insights into the Kidney Stones Application Segment

The kidney stones application segment is expected to hold 28.3% of the lithotripsy devices market revenue share in 2025, establishing it as the dominant application area. Its leadership is being supported by the rising incidence of nephrolithiasis, driven by dietary patterns, lifestyle changes, and increasing metabolic disorders worldwide. Lithotripsy offers a safe and effective alternative to invasive surgical interventions, reducing hospitalization duration and associated healthcare costs.

Integration of advanced imaging systems and real-time energy delivery optimization has enhanced treatment outcomes, improving patient satisfaction and procedural adoption. Hospitals and urology centers are increasingly implementing these solutions as first-line therapy for stone fragmentation.

The segment’s growth is also reinforced by government initiatives promoting early diagnosis and treatment of urinary disorders, as well as expanding awareness campaigns targeting kidney health As patient preference shifts toward minimally invasive procedures, the kidney stones application is expected to remain the primary driver of market growth in the coming years.

Insights into the Hospitals End-Use Segment

The hospitals end-use segment is projected to capture 43.9% of the lithotripsy devices market revenue share in 2025, making it the largest end-use category. Its dominance is being driven by the widespread availability of lithotripsy devices in tertiary care centers, specialized urology clinics, and multi-specialty hospitals. Hospitals benefit from comprehensive infrastructure, trained personnel, and integration of imaging and monitoring systems, allowing for safe and efficient procedures.

The segment’s growth is supported by increasing hospital investments in advanced medical equipment to improve patient outcomes, reduce procedure time, and enhance service quality. Rising patient volumes and demand for outpatient treatment options are further reinforcing adoption. Additionally, hospitals prioritize devices that offer procedural versatility, reliability, and minimal maintenance requirements.

The ability to provide minimally invasive solutions for common urinary disorders positions hospitals as the primary channel for device utilization Ongoing expansion of hospital networks in emerging economies and investments in advanced clinical technologies are expected to sustain this segment’s leadership in the global market.

Market Overview

Devices used in lithotripsy, a minimally invasive surgical process that is used to treat stones like particles in the kidney, ureter, or bladder that are too big to pass through the urinary tract, are referred to as lithotripsy devices. The usual method is to detect the stone using ultrasound or fluoroscopy, then transmit shock waves or strong ultrasonic energy waves straight to it to further shatter it into smaller fragments that can flow out by the urinary system.

What are the Major Drivers Boosting the Demand for Lithotripsy Devices Market?

The important factor driving the growth of the lithotripsy devices market in the forecast period is the increasing elderly population that has been seen around the world. Additionally, factors like rising investment levels in the creation of cutting-edge technology and supportive government regulations for diagnostic procedures like X-ray and urine microscopy tests as well as the rising incidence of urolithiasis diseases all contribute to the market's overall expansion.

Furthermore, the increasing rate of extracorporeal shock wave lithotripsy procedures performed is propelling market growth. Extracorporeal shock wave lithotripsy is a non-invasive procedure that causes no harm to the kidney. It is the most convenient procedure and has become a choice for the treatment of urinary stone removal. Thus, the benefits of extracorporeal shock wave lithotripsy devices are fuelling the demand for lithotripsy devices, which is helping the market to propel.

Which Region Shows Strong Growth Potential in the Lithotripsy Devices Market?

The lithotripsy devices market is broadly segmented into seven major regions, North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East and Africa.

North America is dominating the global lithotripsy devices market due to the increasing rate of surgeries for kidney stones. A large number of the female population as compared to males are more likely to have renal disorders. Chronic renal disorders are common across the region. Thus, the demand for lithotripsy devices is expected to grow in this region.

Apart from North America, the European lithotripsy market is also expected to experience lucrative growth in the forecast years. East Asia and South Asia region is predicted to show rapid growth due to the rising adoption of developed technologies, owing to the rising awareness about the devices and technology along with the developed infrastructure. Latin America, and the Middle East and Africa are expected to grow at a substantial rate in the coming years.

Who are the Key Players in the Lithotripsy Devices Market?

Some of the market players operating in the lithotripsy devices market are Richard Wolf GmbH, MedTech, Bio-Rad Laboratories, Inc., Olympus Corporation, Boston Scientific Corporation, Abaxis, Hologic Inc., DirexGroup, KARL STORZ SE & Co. KG, Lumenis Be Ltd., Dornier MedTech, Walz Elektronik GmbH, and others.

Analysis of Lithotripsy Devices Market By Key Countries

Country	CAGR
China	6.6%
India	6.1%
Germany	5.6%
France	5.1%
UK	4.7%
USA	4.2%
Brazil	3.7%

Country-wise Analysis

The Lithotripsy Devices Market is expected to register a CAGR of 4.9% during the forecast period, exhibiting varied country level momentum. China leads with the highest CAGR of 6.6%, followed by India at 6.1%. Developed markets such as Germany, France, and the UK continue to expand steadily, while the USA is likely to grow at consistent rates. Brazil posts the lowest CAGR at 3.7%, yet still underscores a broadly positive trajectory for the global Lithotripsy Devices Market. In 2024, Germany held a dominant revenue in the Western Europe market and is expected to grow with a CAGR of 5.6%. The USA Lithotripsy Devices Market is estimated to be valued at USD 633.5 million in 2025 and is anticipated to reach a valuation of USD 952.7 million by 2035. Sales are projected to rise at a CAGR of 4.2% over the forecast period between 2025 and 2035. While Japan and South Korea markets are estimated to be valued at USD 88.3 million and USD 46.1 million respectively in 2025.

Key Players in the Lithotripsy Devices Market

• Richard Wolf GmbH
• MedTech
• Bio-Rad Laboratories, Inc.
• Olympus Corporation
• Boston Scientific Corporation
• Abaxis
• Hologic Inc.
• DirexGroup
• KARL STORZ SE & Co. KG
• Lumenis Be Ltd.
• Dornier MedTech
• Walz Elektronik GmbH

Scope of the Report

Item	Value
Quantitative Units	USD 1.7 Billion
Type	Extracorporeal Shock Wave Lithotripsy Devices and Intracorporeal Lithotripsy Devices
Application	Kidney Stones, Ureteral Stones, Pancreatic Stones, and Bile Duct Stones
End User	Hospitals, Ambulatory Surgical Centers, and Speciality Clinics
Regions Covered	North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Country Covered	United States, Canada, Germany, France, United Kingdom, China, Japan, India, Brazil, South Africa
Key Companies Profiled	Richard Wolf GmbH, MedTech, Bio-Rad Laboratories, Inc., Olympus Corporation, Boston Scientific Corporation, Abaxis, Hologic Inc., DirexGroup, KARL STORZ SE & Co. KG, Lumenis Be Ltd., Dornier MedTech, and Walz Elektronik GmbH

Lithotripsy Devices Market by Segments

Type:

• Extracorporeal Shock Wave Lithotripsy Devices
• Intracorporeal Lithotripsy Devices

Application:

• Kidney Stones
• Ureteral Stones
• Pancreatic Stones
• Bile Duct Stones

End User:

• Hospitals
• Ambulatory Surgical Centers
• Speciality Clinics

Region:

• North America
  • USA
  • Canada
  • Mexico
• Latin America
  • Brazil
  • Chile
  • Rest of Latin America
• Western Europe
  • Germany
  • UK
  • Italy
  • Spain
  • France
  • Nordic
  • BENELUX
  • Rest of Western Europe
• Eastern Europe
  • Russia
  • Poland
  • Hungary
  • Balkan & Baltic
  • Rest of Eastern Europe
• East Asia
  • China
  • Japan
  • South Korea
• South Asia and Pacific
  • India
  • ASEAN
  • Australia & New Zealand
  • Rest of South Asia and Pacific
• Middle East & Africa
  • Kingdom of Saudi Arabia
  • Other GCC Countries
  • Turkiye
  • South Africa
  • Other African Union
  • Rest of Middle East & Africa